BMO Capital Maintains Outperform on CareTrust REIT, Lowers Price Target to $45

Benzinga Newsdesk www.benzinga.com Negative 95.5%

Neg 95.5% Neu 0% Pos 0%

BMO Capital analyst Juan Sanabria maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $47 to $45.